Medical Market 

Currently there are few products in the medical field that provide accurate point of care results.  Most testing involves time consuming and costly methods such as NAAT/PCR. The NAAT/PCR test is based on the replication of DNA.  However, this testing is flawed.  NAAT/PCR is affected by inhibitory factors which will yield false negative results.  NAAT/PCR will also replicate dead microorganisms, thus providing false positive results.

The FluoroQuik system detects enzymes, and enzymes are only produced by live viable organisms.  Therefore, a false positive result should not occur and the results can be obtained within minutes of obtaining a sample.

Other diagnostic products on the market that are point of care oriented utilize a system called lateral flow (similar to pregnancy tests).  Lateral flow tests are not considered accurate.  For example, tests for Chlamydia average between 50% to 65% in accuracy. 

The diagnostic method of utilizing enzyme detection is highly accurate as the substrates utilized in the FluoroQuik assays are specific to the target organism.

For the medical industry, the FluoroQuik system will analyze samples taken with a swab, or from blood, urine, or sputum.  Again, the results are available within 5 minutes. 

Click the button below for a partial list of potential products: